Accession Number: | 0001179110-21-006778 |
Date: | 2021-06-14 |
Issuer: | EDITAS MEDICINE, INC. (EDIT) |
Original Submission Date: |
SHEARMAN MARK S
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE, MA 02141
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-14 | A | 32,701 | a | $0.00 | 32,701 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 38.53 | 2021-06-14 | deemed execution date | A | 52,718 (a) | 2031-06-13 | common stock 52,718 | $38.53 | 52,718 | direct |
ID | footnote |
---|---|
f1 | the common stock received by the reporting person was in connection with the grant of a restricted stock unit award to the reporting person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on june 14, 2022 continuing through june 14, 2025. |
f2 | this option was granted on june 14, 2021 and is scheduled to vest over four years, with 25% of the shares to vest on june 14, 2022 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through june 14, 2025. |